Background: Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease due to smoking. It is avertable as well as treatable. COPD is a one of the main cause of morbidity and mortality affecting developed and developing countries. We aim to estimate burden of anemia at a tertiary care public sector hospital. Methods: This is a descriptive cross sectional study, done at JPMC Karachi in 2014. All COPD patients admitted in medicine and pulmonology departments were enrolled in this study. After informed consent, data of complete blood count was accessed from medical record and anemia was labeled as per operational definition. Data analyzed by SPSS version 16.0. Frequency and percentage proportion of qualitative variables, mean and standard deviation of numerical values were calculated with P value <0.05 was taken as significant. Results: Of 137 cases, 118(86.13%) were males and 19(13.87%) were females while male to female ratio was 6.2: 1. The average age and weight of the patients was 58.31±12.17 years and 59.36±10.56kg, similarly average duration of disease and hemoglobin of the patients was 5.69±4.42 years and 12.34±1.58 mg/dl respectively. 37.96% (52/137) patients were anemic in our study. Rate of anemia in COPD patients was not significant among age groups (p=0.076) and with duration of disease (p=0.22). Conclusion: Anemia seems to be a common feature in COPD (37.96%), mechanisms involved in the genesis of anemia in COPD are poorly studied. Low hemoglobin level can have adverse effects on certain respiratory parameters in COPD, increasing morbidity and mortality.
Biotransformation in human body results accumulation of free radicals (reactive oxygen species or ROS). If patients LDL particles are more than normal in systemic circulation, get interacted with free radicals and form foamy cells; initial stage of coronary artery disease (CAD). Hyperlipidemia may be primary (genetic reason) or secondary which is acquired type of dyslipidemia. Free radicle formation in human body is very much normal phenomenon. Just reducing LDL or raising HDL may prevent interaction of LDL with reactive oxygen species (free radicals), escaping patient to develop CAD. Commonly used drugs in prophylaxis or treatment of dyslipidemia include statins (HMGCo-A reductase inhibitors), niacin, bile resins and fibric acids. There are alternative therapies for dyslipidemia including use of fibers, fruits, and vegetables. In Pakistan there are huge number of fruits and herbs which are getting popularity as hypolipidemic agents. One of the important fruit in Pakistan having hypolipidemic potential is JUJUBES (in urdu called Bair). In this study we have compared hypolipidemic effects of Bair with statin in hyperlipidemic patients. This study was conducted at Begum Jan hospital, Islamabad-Pakistan. Sixty hyperlipidemic patients were selected and divided in two groups. Their lipid profile (LP) was determined in the hospital and blood pressure (BP) was recorded at start of treatment. Group-1 was advised to take 10 mg tablet Rosuvastatin in divided doses, and group-2 was advised to use 500 mg Bair (JUJUBES) in divided times per day for the period of 2 months. RESULTS: after two months therapy their lipid profile and BP was re-determined and analyzed statistically by using SPSS version 22.00.01. It was observed that Rosuvastatin decreased systolic BP and LDL-c highly significantly (p-value < 0.001), while diastolic BP was reduced significantly (p-value <0.01) and HLD-c was increased significantly with p-value <0.01. In group-2 JUJUBES (Bair) reduced systolic BP and LDL-c significantly (p-value <0.01) but no significant changes were observed in diastolic BP and HDL-c in this group. CONCLUSION: It was concluded from the research study that Jujubes reduce LDL-c and systolic BP in hyperlipidemic patients, but lesser than statin group of antihyperlipidemic agents.
Metabolic syndrome comprises of altered lipid, carbohydrates, and protein metabolism causing increase synthesis of reactive oxygen species (ROS) which interact with blood low density lipoprotein (LDL) particles. This interactive phenomenon develops coronary artery disease (CAD) causing hypertension, congestive cardiac failure, cardiac arrhythmias, and heart attack. Preventive measures for CAD include avoiding sedentary life style, cession of cigarette smoking, taking unhealthy bakery foods and taking hypolipidemic agents. In allopathy hypolipidemic agents include statins, fibrates, niacin and psyllium husk. Because these drugs have mild to severe adverse effects, medicinal herbs having hypolipidemic characteristics are replacing allopathic agents. Ginger is one of those medicinal herbs. We have tried to prove how much ginger can reduce LDL-C, TC, and body weight in hyperlipidemic patients. Our research work was single blind and placebo-controlled study. The study was conducted at National Hospital, Lahore, Pakistan from July to November 2016. 65 male, female hyperlipidemic patients were selected from the OPD of the Hospital. Their age range was 25 years to sixty years. Chain smokers, regular alcohol users, and patients suffering from any liver, kidney, and gastrointestinal illnesses were excluded from the study. They were divided equally ie 30 patients in each group. Group-I was tested group and Group-II was placebo group. Their baseline lipid profile, and body weight was determined in pathology laboratory of the hospital and was kept in their personal file. Serum TC (total cholesterol) by calorimetric (enzymic) method. Blood LDL-cholesterol was calculated by Friedwald formula5 ie; LDL-cholesterol = TC-(TG/5) + HDL-cholesterol. 30 patients of group-I were advised to take 5 grams ginger’s pasted-powder in divided doses for the period of three months. 30 patients of group-II were advised to take one capsule (placebo capsule filled with 30 mg of grinded wheat) 8 hourly daily for the period of three months. They were advised to come at hospital for follow up fortnightly. After three months therapy their lipid profile and body weight was redetermined by same method as above. Data were expressed as mean ± SD/SEM (standard deviation/ standard error of mean). Paired t-test was used to determine SS (statistical significance) in pre and post-treatment mean values. P-values greater than 0.05 were labeled as non-significant difference in two groups (pre-treatment and post treatment mean values). Lesser than 0.05 value (p-value) was considered as significant change in two groups. Lesser than 0.001 value was labeled as highly significant change in two groups (pre-treatment and post treatment groups).
Coronary artery disease is a complex syndrome to get initiation from formation of atherosclerotic plaques in systemic circulation to cardiac arrhythmia causing morbidity/mortality. This study was conducted to compare hypolipidemic effects of Niacin and Indian date (Jujuba) in hyperlipidemic patients. Study was conducted from July 2019 to December 2019 at National Hospital Lahore-Pakistan. Sixty participants were enrolled of both gender male and female patient’s age range from 25 to 60 years. Consent was taken from all patients. They were divided in two groups. Group-I was advised to take 2 grams Niacin in divided doses for the period of two months. Group-II was advised to take 500 grams of fruit Jujube daily for the period of two months. All patients’ systolic and diastolic blood pressure was noted. Their baseline LDL and HDL cholesterol was determined by conventional method of measuring Lipid Profile. After two months therapy, their post treatment blood pressure and lipid profile was measured and mean values with ± SEM were analyzed biostatistically. Group-I which was on Niacin their blood pressure was reduced but it was non-significant change, LDL cholesterol decreased significantly and HDL cholesterol was increased significantly. In group-II patients LDL cholesterol was decreased significantly but HDL increase was not significant with p-value of >0.05. It was concluded from the research work that Niacin is potent in lowering LDL and increasing HDL cholesterol, while Jujube has significant effect as LDL cholesterol lowering potential, but it does not increase HDL cholesterol significantly. Jujubes and vitamin B-3 did not reduced blood pressure, when analyzed statistically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.